Education
About Us
Working with TipRanks
Follow Us
Genscript Biotech (HK:1548)
:1548
1548 Analyst Ratings
Hold
0 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
1548 Stock 12 Month Forecast
Average Price Target
HK$16.01
▲(4.26%Upside)
| Highest Price TargetHK$16.00 | Average Price TargetHK$16.01 | Lowest Price TargetHK$16.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
HK$16
Hold
4.17%
Upside
Reiterated
06/19/25
Unknown AnalystMorgan Stanley
Not Ranked
Morgan Stanley
HK$18.6→HK$21.9
Buy
42.58%
Upside
Reiterated
03/14/25
We lift our PT for GenScript and maintain our OW rating on the company due to three things: 1) GenScript's leading-edge technology platform and industry position in protein and the gene synthesis area with limited qualified competitors; 2) recovery order trend in the CRO and CDMO segments with eased geopolitical overhangs, and 3) outperforming enzyme business thanks to growing wallet share from key account clients as well as accelerated ex-China market expansion.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
HK$16
Hold
4.17%
Upside
Reiterated
06/19/25
Unknown AnalystMorgan Stanley
Not Ranked
Morgan Stanley
HK$18.6→HK$21.9
Buy
42.58%
Upside
Reiterated
03/14/25
We lift our PT for GenScript and maintain our OW rating on the company due to three things: 1) GenScript's leading-edge technology platform and industry position in protein and the gene synthesis area with limited qualified competitors; 2) recovery order trend in the CRO and CDMO segments with eased geopolitical overhangs, and 3) outperforming enzyme business thanks to growing wallet share from key account clients as well as accelerated ex-China market expansion.
Best Analysts Covering Genscript Biotech
1 Month
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
3 Months
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
1 Year
Unknown AnalystMorgan Stanley
Not Ranked
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a buy rating 4 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
1548 Analyst Recommendation Trends
Rating
Mar 24
May 24
Mar 25
May 25
Jun 25
Strong Buy
2
3
3
2
1
Buy
0
0
0
0
0
Hold
1
0
0
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
1548 Financial Forecast
1548 Stock Forecast FAQ
What is HK:1548’s average 12-month price target, according to analysts?
Based on analyst ratings, Genscript Biotech’s 12-month average price target is 16.01.
What is HK:1548’s upside potential, based on the analysts’ average price target?
Genscript Biotech has 4.26% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Genscript Biotech a Buy, Sell or Hold?
Genscript Biotech has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Genscript Biotech’s share price target?
The average share price target for Genscript Biotech is 16.01. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$16.00 ,and the lowest forecast is HK$16.00. The average share price target represents 4.26% Increase from the current price of HK$15.36.
The highest analyst share price target is HK$16.00 ,and the lowest forecast is HK$16.00. The average share price target represents 4.26% Increase from the current price of HK$15.36.
What do analysts say about Genscript Biotech?
Genscript Biotech’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Genscript Biotech?
To buy shares of HK:1548, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.